http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-064975-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f32653b31a38b163a9f2f04aab36d47c |
| filingDate | 2008-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e493e82e054102340e69d7f1e3d3ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b6e9bdf44e156ae636ef0e8a63f6156 |
| publicationDate | 2009-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-064975-A1 |
| titleOfInvention | MEDICINAL PRODUCT THAT CONTAINS NATURAL INHIBITORS OF LEUCOTRENEES INDIVIDUALLY OR IN COMBINATION WITH A SUPPLEMENT OF BIODISPONIBLE ORGANIC SELENIUM FOR HYPERPROLIFERATIVE DERMATOLOGICAL DISEASES AND THERAPEUTIC METHODS FOR THE SAME. |
| abstract | Medication and its use in a method for the therapeutic treatment of hyperproliferative diseases of the skin, in particular psoriasis on the skin, scalp and ones. The drug includes a dual inhibitor of 5-lipoxygenase and human leukocyte elastase, simple or in combination with a bioavailable organic selenium nutritional supplement. In particular, the medicament includes: a) an oral formulation comprising acetyl-11-keto-beta-boswellic acid in combination with a bioavailable organic selenium nutritional supplement, dispersed in a pharmaceutically acceptable carrier, and b) a topical formulation comprising acid acetyl-11-keto-beta-boswellic alone, dispersed in a pharmaceutically acceptable carrier. This medication has been shown to be efficient for the therapeutic treatment of clinical psoriasis with its ability to (i) provide relief from clinical symptoms and (ii) its ability to eliminate psoriatic lesions as evaluated in a phase III clinical study of three months, multi-center, prospective and open. |
| priorityDate | 2007-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.